A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy

J Stebbing; A Sharma; B North; T J Athersuch; A Zebrowski; D Pchejetski; R C Coombes; J K Nicholson; H C Keun

doi:10.1093/annonc/mdr347

A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy

J Stebbing, A Sharma, B North, T J Athersuch, A Zebrowski, D Pchejetski, R C Coombes, J K Nicholson, H C Keun

Research output: Contribution to journal › Article › peer-review

44 Citations (Scopus)

Abstract

Breast cancer is associated with adverse outcomes in patients with the metabolic syndrome phenotype. To study this further, we examined the relationship between serum metabolite levels and the components of metabolic syndrome with treatment outcomes in breast cancer.

Original language	English
Pages (from-to)	860-866
Number of pages	7
Journal	Annals of Oncology
Volume	23
Issue number	4
DOIs	https://doi.org/10.1093/annonc/mdr347
Publication status	Published - Apr 2012

Keywords

Adult
Aged
Aged 80 and over
Blood Glucose
Blood Pressure
Breast Neoplasms
Female
Humans
Logistic Models
Metabolic Syndrome X
Middle Aged
Multivariate Analysis
Phenotype
Postmenopause
Treatment Outcome
Triglycerides

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdr347Licence: Other

Cite this

@article{ae62aa31efd94ff0946c9630fdde17cb,

title = "A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy",

abstract = "Breast cancer is associated with adverse outcomes in patients with the metabolic syndrome phenotype. To study this further, we examined the relationship between serum metabolite levels and the components of metabolic syndrome with treatment outcomes in breast cancer.",

keywords = "Adult, Aged, Aged 80 and over, Blood Glucose, Blood Pressure, Breast Neoplasms, Female, Humans, Logistic Models, Metabolic Syndrome X, Middle Aged, Multivariate Analysis, Phenotype, Postmenopause, Treatment Outcome, Triglycerides",

author = "J Stebbing and A Sharma and B North and Athersuch, {T J} and A Zebrowski and D Pchejetski and Coombes, {R C} and Nicholson, {J K} and Keun, {H C}",

year = "2012",

month = apr,

doi = "10.1093/annonc/mdr347",

language = "English",

volume = "23",

pages = "860--866",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy

AU - Stebbing, J

AU - Sharma, A

AU - North, B

AU - Athersuch, T J

AU - Zebrowski, A

AU - Pchejetski, D

AU - Coombes, R C

AU - Nicholson, J K

AU - Keun, H C

PY - 2012/4

Y1 - 2012/4

N2 - Breast cancer is associated with adverse outcomes in patients with the metabolic syndrome phenotype. To study this further, we examined the relationship between serum metabolite levels and the components of metabolic syndrome with treatment outcomes in breast cancer.

AB - Breast cancer is associated with adverse outcomes in patients with the metabolic syndrome phenotype. To study this further, we examined the relationship between serum metabolite levels and the components of metabolic syndrome with treatment outcomes in breast cancer.

KW - Adult

KW - Aged

KW - Aged 80 and over

KW - Blood Glucose

KW - Blood Pressure

KW - Breast Neoplasms

KW - Female

KW - Humans

KW - Logistic Models

KW - Metabolic Syndrome X

KW - Middle Aged

KW - Multivariate Analysis

KW - Phenotype

KW - Postmenopause

KW - Treatment Outcome

KW - Triglycerides

U2 - 10.1093/annonc/mdr347

DO - 10.1093/annonc/mdr347

M3 - Article

C2 - 21821546

VL - 23

SP - 860

EP - 866

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 4

ER -